AIE is a spin-off of SAIA (an NGO), a world leader in AI biomedical applications. In the last 15 years, we developed the best non-invasive multi-cancer diagnosis and early detection test. It’s based on >6000 patients, advanced AI, and works on 13 cancers with >99% accuracy. It avoids patients’ fear, pain, and risks (liquid biopsy: drop of blood), dramatically increasing survival rate and decreasing treatment cost (more details here https://cordis.europa.eu/article/id/411554-artificial-intelligence-enhances-cancer-diagnostic-testing?WT.mc_id=exp). Our vision considers the paradigm shift biomedicine is facing now, moving from invasive surgical procedures to liquid biopsies and from old-fashion statistics to Data Science and AI. We also use an Intelligent Automation (IA = Digital Automation + AI) approach to automate clinical workflows, freeing physicians from memorizing best practice approaches and let them spend more time with patients. Also, we are working hard on finishing the development of our biomarker discovery platform this year.